What happens when you suddenly remove half of an essential enzyme from cells? 🤔
We watched in real-time as cells deploy multiple backup strategies to buffer against changes in RNA Pol II abundance.
Our lab's new preprint 👇
https://t.co/GMUYJnieG9
What happens when you suddenly remove half of an essential enzyme from cells? 🤔
We watched in real-time as cells deploy multiple backup strategies to buffer against changes in RNA Pol II abundance.
Our lab's new preprint 👇
https://t.co/GMUYJnieG9
📢 New paper from the lab!
In a fantastic new collaboration with @ana_tufegdzic lab, we characterise a major Pol II homeostasis pathway in human cells. Congratulations Roberta @caciopporobi, Alex @acftbl, Ivan @IvanShlamovitz, and Andrew.
https://t.co/B4xOaHDR7V
The first paper from our lab is online! A wonderful collaboration with @scottbscience lab. We discover that Pol II is extensively regulated by Ubiquitin at the beginning of the transcription cycle! 🧵
https://t.co/V4lI2lEmhs
Global transcription regulation revealed from dynamical correlations in time-resolved single-cell RNA sequencing @CellSystemsCP
@DVolteras@VShahrezaei
https://t.co/JgLDygkBC2
Genome-wide quantification of RNA flow across subcellular compartments reveals determinants of the mammalian transcript life cycle
https://t.co/sPoFmZu5Uk
Published @MolecularCell
Big thanks to
fellow co-first authors @BrendanSmalec Albert Xu
@stephenfloor
mentor @fiddle
+team!
We were selected for the cover! our papers under the spotlight in the current issue of @MolecularCell. Congratulations to Govind Menon for his beautiful design 😍☺️
Cofactors are a crucial part of the gene activation process. Yet, we still don't have a comprehensive understanding of how and why they are used by different genes. Proud to present our attempt to address this key question, now published
https://t.co/wdDmHDMDCI
1/2 The @nswdpi pilot project to fast-track an mRNA vaccine for border disease virus (BDV) has been successfully manufactured for the first time in NSW by the @UNSWRNA.
We at the @UNSWRNA team are very proud of this that @dpinsw led! First batch of an animal mRNA vaccine that was made here in Australia by us in March in collaboration with @Tibabiotech who developed this vaccine. #mRNA
Australian PhD candidates & Early Career Scientists, don’t miss this opportunity to participate in a dedicated 2 day program in the lead up to Biomolecular Horizons 2024. Connect with colleagues from across the globe! Visit https://t.co/tcLNjq15Jk Applications close 29 Feb 2024